The Traderszone Network

Published in TZ Latest News 17 November, 2014 by The TZ Newswire Staff

Actavis to spend $66B on Allergan

Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally end a months-long takeover push from Valeant Pharmaceuticals for the Botox maker. Actavis said Monday that it …